GILEAD SCIENCES, INC. (GILD) earnings date

Nasdaq · Megacap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 36 days, typically, give or take 6 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Thu, Oct 29, 2026after close 29 8-K
Q2 FY2026Tue, Aug 4, 2026after close 35 8-K
Q1 FY2026Thu, May 7, 2026after close 37 8-K
Q4 FY2025Tue, Feb 10, 2026after close 41 8-K
Q3 FY2025Thu, Oct 30, 2025after close 30 8-K
Q2 FY2025Thu, Aug 7, 2025after close 38 8-K
Q1 FY2025Thu, Apr 24, 2025after close 24 8-K
Q4 FY2024Tue, Feb 11, 2025after close 42 8-K

What they guided beta

Q3 FY2026 "“Our performance enabled us to raise our full year base business revenue guidance again this quarter, bringing the total increase to $1.6 billion since the start of 2026." exhibit
Q3 FY2026 "Total third quarter 2026 product sales increased 13% to $8.3 billion compared to the same period in 2025, primarily driven by higher sales of HIV products, Trodelvy® (sacituzumab govitecan-hziy) and Livdelzi® (seladelpar), partially offset by lower sales of Veklury® (remdesivir) and Cell Therapy products." exhibit
Q3 FY2026 "Total third quarter 2026 product sales excluding Veklury increased 16% to $8.2 billion compared to the same period in 2025, primarily due to higher sales of HIV products, Trodelvy and Livdelzi, partially offset by lower sales of Cell Therapy products." exhibit
Q3 FY2026 "The Liver Disease portfolio sales increased 13% to $927 million in the third quarter 2026 compared to the same period in 2025, primarily reflecting higher demand for Livdelzi, as well as higher average realized price for chronic hepatitis C virus (“HCV”) and chronic hepatitis B virus products, partially offset by lower demand for HCV products." exhibit
Q3 FY2026 "Veklury sales decreased 69% to $86 million in the third quarter 2026 compared to the same period in 2025, primarily driven by lower rates of COVID-19-related hospitalizations." exhibit
Q2 FY2026 "Total second quarter 2026 product sales excluding Veklury increased 10% to $7.6 billion compared to the same period in 2025, primarily due to higher sales of HIV products, Trodelvy and Livdelzi, partially offset by lower sales of Cell Therapy and HCV products." exhibit
Q2 FY2026 "The Liver Disease portfolio sales increased 10% to $877 million in the second quarter 2026 compared to the same period in 2025, primarily reflecting higher demand for Livdelzi, as well as chronic hepatitis B virus (“HBV”) products and Hepcludex® (bulevirtide-gmod), partially offset by lower sales for HCV products." exhibit
Q2 FY2026 "Veklury sales decreased 81% to $23 million in the second quarter 2026 compared to the same period in 2025, primarily driven by lower rates of COVID-19-related hospitalizations." exhibit
Q2 FY2026 "Research and development (“R&D”) expenses were $1.8 billion in the second quarter 2026 compared to $1.5 billion in the same period in 2025, primarily due to integration costs and other acquisition-related expenses, partially offset by lower oncology clinical study activity." exhibit
Q2 FY2026 "Non-GAAP R&D expenses were $1.4 billion in the second quarter 2026 compared to $1.5 billion in the same period in 2025, primarily driven by lower oncology clinical study activity." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/GILD
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/GILD

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

GILD earnings date badge

HTML

<a href="https://veritasdata.dev/company/GILD/"><img src="https://veritasdata.dev/embed/GILD.svg" alt="GILD earnings date" width="240" height="56"></a>

Markdown

[![GILD earnings date](https://veritasdata.dev/embed/GILD.svg)](https://veritasdata.dev/company/GILD/)

Script

<script async src="https://veritasdata.dev/embed/GILD.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/GILD"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.